CLDI financials

Calidi Biotherapeutics (CLDI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

CLDI income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$20.24M-$25.58M-95.20
2024––-$21.78M-$23.81M-571.20
2023––-$28.99M-$29.22M-3327.36
2022$45.00K–-$23.13M-$25.43M5740.80